Novel urinary biomarkers in pre-diabetic nephropathy

详细信息    查看全文

• 作者：Vikas Garg ; Manish Kumar ; Himansu Sekhar Mahapatra…
• 关键词：Pre ; diabetes ; Diabetic nephropathy ; Cystatin C ; NGAL
• 刊名：Clinical and Experimental Nephrology
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：19
• 期：5
• 页码：895-900
• 全文大小：449 KB
• 参考文献：1.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:s81鈥?0.CrossRef
  2.Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis. 2005;12:177鈥?6.CrossRef PubMed
  3.Comper WD, Hilliard LM, Nikolic-Paterson DJ, Russo LM. Disease dependent mechanism of albuminuria. Am J Physiol Renal Physiol. 2008;295:F1589鈥?00.CrossRef PubMed
  4.Krolewski AS, Niewczas MA, Skupien J, et al. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. 2014;37:226鈥?4.PubMed Central CrossRef PubMed
  5.Molitch ME, Steffes M, Sun W, Epidemiology of Diabetes Interventions and Complications Study Group, et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care. 2010;33:1536鈥?3.PubMed Central CrossRef PubMed
  6.Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289:3273鈥?.CrossRef PubMed
  7.National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60:850鈥?6.CrossRef
  8.Barratt J, Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ. 2007;177:361鈥?.PubMed Central CrossRef PubMed
  9.Jeon YK, Kim MR, Huh JE, Mok JY, et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean Med Sci. 2011;26:258鈥?3.PubMed Central CrossRef PubMed
  10.Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med. 2010;27(10):1144鈥?0.CrossRef PubMed
  11.Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221鈥?.CrossRef PubMed
  12.Filler G, Bokenkamp A, Hofmann W, Le Bricon T, et al. Cystatin C as a marker of GFR -history, indications, and future research. Clin Biochem. 2005;38:1鈥?.CrossRef PubMed
  13.Yang J, Mori K, Li JY, Barasch J. Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol. 2003;285:F9鈥?8.CrossRef PubMed
  14.Mishra J, Ma Q, Prada A, Mitsnefes M, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534鈥?3.CrossRef PubMed
  15.Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. Neutrophil gelatinase associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004;24:307鈥?5.CrossRef PubMed
  16.Mishra J, Dent C, Tarabishi R, Mitsnefes MM, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231鈥?.CrossRef PubMed
  17.Kim SS, Song SH, Kim IJ, Jeon YK, et al. Urinary Cystatin C and Tubular proteinuria predict progression of diabetic nephropathy. Diabetes Care. 2013;36:656鈥?1.PubMed Central CrossRef PubMed
  18.Nauta FL, Boertien WE, Bakker SJL, Goor HV, et al. Glomerular markers are elevated in patients with diabetes. Diabetes Care. 2011;34:975鈥?1.PubMed Central CrossRef PubMed
  19.Wu J, Ding Y, Zhu C, Shao X, et al. Urinary TNF-伪 and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. Exp Ther Med. 2013;6:1482鈥?.PubMed Central PubMed
  20.Fu WJ, Li BL, Wang SB, Chen ML, et al. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract. 2012;95(1):105鈥?.CrossRef PubMed
  21.Holman RR, Paul SK, Bethel MA, Matthews DR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577鈥?9.CrossRef PubMed
  22.Remuzzi G, Macia M, Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol. 2006;17(S2):S90鈥?.CrossRef PubMed
  23.Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253鈥?.CrossRef
  24.Borgman JM, Skorecki K. Chronic kidney disease. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL,editors. Harrison鈥檚 principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. p. 2308鈥?321.
  25.Levey AS, Bosch JP, Lewis JB, Green T, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461鈥?0.CrossRef PubMed
  26.Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis. 2004;44(5):792鈥?.CrossRef PubMed
  27.Tarsio JF, Reger LA, Furcht LT. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association. Diabetes. 1988;37(5):532鈥?.CrossRef PubMed
  28.Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, et al. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab. 2007;293:E1311鈥?.CrossRef PubMed
  29.Makris K, Nikolaki E, Nanopoulos K, Pirqakis KM, et al. Measurement of Cystatin C in human urine by particle enhanced turbidimetric immunoassay on automated biochemistry analyzer. Clin Biochem. 2013;46(12):1128鈥?0.CrossRef PubMed
  30.Conti M, Moutereau S, Zater M, Lallali K, et al. Urinary Cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med. 2006;44(3):288鈥?1.CrossRef PubMed
  31.Woo KS, Choi JL, Kim BR, Kim JE, et al. Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease. Diabetes Metab J. 2012;36:307鈥?3.PubMed Central CrossRef PubMed
  32.Lacquaniti A, Donato V, Pintaudi B, Vieste GD, et al. 鈥樷€楴ormoalbuminuric鈥欌€?diabetic nephropathy: tubular damage and NGAL. Acta Diabetol. 2013;50:935鈥?2.CrossRef PubMed
  33.Assal HS, Tawfeek S, Rasheed EA, Lebedy DE, et al. Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus. Clin Med Insights Endocrinol Diab. 2013;6:7鈥?3.
  34.Fu WJ, Xiong SL, Fang YG, Wen S, et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine. 2012;41(1):82鈥?.CrossRef PubMed
  35.Mori K, Lee HT, Rapoport D, Drexler IR, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115(3):610鈥?1.PubMed Central CrossRef PubMed
  36.Kaseda R, Iino N, Hosojima M, Takeda T, et al. Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochem Biophys Res Commun. 2007;357(4):1130鈥?.CrossRef PubMed
  37.Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008;1(3):200鈥?.PubMed Central CrossRef PubMed
  38.Russo LM, Sandoval RM, Campos SB, et al. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J Am Soc Nephrol. 2006;17:2937鈥?4.CrossRef
  
• 作者单位：Vikas Garg (1)
  Manish Kumar (1)
  Himansu Sekhar Mahapatra (1)
  Anubhuti Chitkara (1)
  Adesh Kumar Gadpayle (1)
  Venketansan Sekhar (1)
  
  1. Room No 307, Admin Block, PGIMER, Dr RML Hospital, New Delhi, India
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Nephrology
  Internal Medicine
  Urology and Andrology
  
• 出版者：Springer Japan
• ISSN：1437-7799

文摘

Background Renal involvement was thought to occur more than 10 years after onset of diabetes, but recent studies provide evidence that it starts even in the pre-diabetes stage. However, there is no sensitive marker to detect these changes at such early stages. Novel urinary biomarkers have showed promising results in detection of early nephropathy in pre-diabetics.